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Hepatic involvement in Wilson disease consists of isolated elevated liver enzyme, 
asymptomatic hepatomegaly, cirrhosis and acute liver failure. Here, we report three 
patients with unexplained elevated liver enzymes. By considering the level of urinary 
excretion of copper after penicillamine challenge test, we had some problems in the 
process of diagnosis. Therefore, we thought of cautiously applying the diagnostic cut-
off in the mentioned challenge test.
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INTRODUCTION
Wilson is an autosomal recessive disorder which is described 
by degenerative changes in brain, liver and Kayser Fleischer 
(KF) ring in cornea. The incidence of this disease is 1 in 30,000 
to 1 in 50,000 live births [1, 2]. A defect in P1B-ATPase which 
is coded by ATP7B on chromosome 13 long arm, is found in 
many of the patients [1]. Hepatic involvement in Wilson disease 
consists of asymptomatic hepatomegaly, subacute or chronic 
hepatitis and acute liver failure (with or without hemolytic ane-
mia). In any child or adolescent with a chronic or unexplained 
acute or chronic elevated liver enzymes, neurological manifes-
tations (tremor, dysarthria, dystonia, chorea, parkinsonism, 
disorders of academic performance and behavioral change), 
acute hemolysis, psychiatric disease (depression, anxiety, psy-
chosis), Fanconi syndrome, unexplained skeletal or muscular 
disease, it is important to consider Wilson disease. In this dis-
ease, Serum ceruloplasmin levels are less than 20 mg/dL, and 
the urinary copper excretion rate is greater than 100 mcg/day 
and mostly more than 1000 micro gram in 24 hours [2]. Due 
to unusual and uncommon manifestations in diagnosis of Wil-
son disease, using chelator challenging test is helpful [3]. With 
administration of 500 mg of D- Penicillamine every 12 hours, 
urinary excretion becomes more than 1600 micrograms per 24 
hours. Detecting the KF ring and performing Liver biopsy to 
measure Hepatic copper concentration (> 250 micrograms) are 
helpful in diagnosis [4]. In this case series we want to present 
three patients with unexplained elevated liver enzyme (ELE) 
for more than one year whom their urinary excretion of copper 
after penicillamine challenge test (PCT) was misguiding.
CASE PRESENTATION
Case 1:
A 10-year-old obese male from Kashan (a city in Esfahan 
province in Iran) presented with chronic abdominal pain from 
3 years ago that has ELE in the investigations since 1 year ago. 
Due to obesity and ELE, complete evaluations of auto immune 
and viral hepatitis, Wilson disease and anatomical abnormali-
ties were performed (table 1). As far as the symptoms and signs 
were not relieved and the investigations were unremarkable, 
liver biopsy was performed and the pathology showed few 
points in favor of WD. Therefore, PCT was considered and it 
was in favor of WD (table 2). Afterwards, Penicillamine was 
prescribed for him as a standard treatment for WD (10-20 mg/
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kg/day). During the 1 year follow up there were no improve-
ment in liver enzymes, therefore, genetic study for WD was 
considered after reevaluation of other probable reasons for ELE 
that was negative and WD was ruled out. The patient is now on 
treatment as a case of nonalcoholic steatohepatitis (NASH) and 
metabolic syndrome.
Case 2:
An 18-year-old male from Urmia (center of west Azerbaijan 
province in Iran) presented with chronic abdominal pain and 
headache from 4 years previous to visit which was intensified 
in the last year. The patients’ mother has been suffering from 
Rheumatoid arthritis since 10 years ago. While evaluating the 
patient, isolated ELE was found. Further complementary eval-
uations (table 1) for viral, auto immune, infiltrative and meta-
bolic liver involvement were done. As far as the symptoms and 
signs were not relieved and the investigations were unremark-
able, liver biopsy was performed and the pathology showed 
few points in favor of WD. Therefore, PCT was considered and 
it was in favor of WD (table 2). Penicillamine was prescribed 
for the patient as a standard treatment for WD (10-20 mg/kg/
day). During follow up there were no improvement in liver en-
zyme, so complete reevaluations including genetic study for 
WD were considered and mutations in ATP7B gene and other 
related genes to WD was negative. From 5 months ago the pa-
tient has showed arthralgia in both knees, considering the pos-
itive family history he was referred to a rheumatologist and all 
of the rheumatologic evaluations were normal. The patient is 
now on treatment as a case of NASH and under rheumatologic 
follow up.
Case 3:
An 18 years old male teenager from Tehran (capital of Iran) 
became a candidate for a hand orthopedic surgery due to a trau-
ma. Thrombocytopenia was detected as an accidental finding in 
pre operation lab data. Due to this finding he was referred to an 
internist. The patient had no history of abdominal pain, nausea 
and vomiting, cutaneous lesions, constipation, ecchymosis, and 
icterus. In further evaluations, ELE and splenomegaly were de-
tected (table 1). SoSo, he was referred to a hematologist and 
,bone marrow aspiration and biopsy were normal. 
In the visit by a gastroenterologist, it was revealed that he also 
has complaint from frontal headache with diffusion to left eye. 
A fine tremor with a progressive process has been established 
in the upper limbs since three months ago and mother of hishis 
mother  reported anxiety disorder symptoms. According to 
moderate splenomegaly, normal hepatic and prehepatic vascu-
lature and liver fibrosis in fibro scan in previous assessments, 
he was considered with hepatic disorders and reevaluation of 
hepatic function and related disorders were done, but nothing 
was found in favor of viral or autoimmune hepatitis and WD. 
Endoscopy findings were also normal. Brain MRI did not show 
any abnormality which could explain tremor. Percutaneous 
Liver biopsy was not possible because of the thrombocytope-
nia, so Penicillamine was prescribed due to positive PCT which 
was suggestive of WD (table 2). In further follow ups for up 
to 6 months, there were no improvement in platelet levels and 
liver enzymes. According to these findings Genetic workup 
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for WD was performed and all of the common mutations were 
negative.
 DISCUSSION
WD has a wide spectrum of clinical presentations, but the most 
common features are hepatic and neurologic ones [5]. Estab-
lishing the diagnosis of WD may be hard especially in chil-
dren with liver disease [1, 5]. Neither the absence of KF rings 
nor normal values of ceruloplasmin can exclude WD. Ceru-
loplasmin has been shown to have sensitivity and specificity of 
82.4% and 94.4%, respectively [5]. In the present case series, 
low serum ceruloplasmin was found in all 3 cases and none 
of our cases was presented with KF rings. KF rings may be 
absent in only 5% of cases with neurological presentation but 
it is usually absent in children presenting with liver disease [5]. 
A urinary copper excretion more than 100 μg/24 hr is helpful 
in diagnosing WD and if it is greater than 40 μg/24 hr, further 
investigations should be done to confirm WD diagnosis [1, 4]. 
Copper values are often normal in children with mild hepatic 
involvement [4]. All 3 cases in our study had Urine Copper 
excretion lower than 40 μg/24 hr. A positive PCT (>1600 μg/24 
hr) is a confirming finding in patients with WD [1, 4, 5]. The 
PCT (i.e. 0.5 g D-penicillamine given at the beginning of the 
24-hour urine collection and 12 hours later) is not enough to 
confirm the diagnosis in asymptomatic children with a sensi-
tivity of 12% [1]. Decreasing the cut-off to 5 times the upper 
normal range of basal urinary copper excretion (200 mg/24 hr) 
increased the sensitivity to 88% but the specificity lowered to 
24.1% [1, 3]. We have used this scale for suspecting WD for 
the three patients as their PCT was lower than 1600 μg/24 hr 
but 5 time greater than upper normal limit (UNL). The WD 
scoring system proposed by Ferenci et al. [8] maybe a reliable 
tool in this subset of patients if this limit is used for evalu-
ating the 24-hour urinary copper excretion. In these patients 
PCT cannot help much for diagnosis [1, 2]. A genetic study 
is valuable in such patients [1, 2]. In our study, genetic assay 
showed no mutations in ATP7B gene and other related genes 
to WD. In the present case series, the PCT gave low values in 
all three WD suspected patients. Although our patients had a 
positive PCT of 5 times more than UNL as a diagnostic criteria 
by some studies whilst they were followed up on treatment, it 
was revealed that they were misdiagnosed as WD.
CONCLUSION
The manifestations of WD in children are very diverse. It is dif-
ficult to make a definitive diagnosis with minimum rare man-
ifestations. A single positive or negative diagnostic test is not 
enough to confirm or ruleout WD. A positive PCT with a cop-
per excretions 5 times more than UNL in the patients suspicious 
of WD is not enough to confirm the diagnosis. A positive PCT 
should be mentioned when urinary copper excretion is >1600 
μg/24 hr to make the correct diagnosis. In the cases with equiv-
ocal PCT, positive mutation in ATP7B gene and other related 
genes to WD can be helpful to make a definite diagnosis.
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TABLE 1. Complementary evaluations for WD
Case 1 Case 2 Case 3
Plasma ceruloplasmin (mg/dL) 41 23.4 15
Urine Copper excretion  (μg/24 hr) 35 31 21
Urine copper (24 hr) post D- penicillamine challenge test (μg/24 hr) 452 572 1206
Hepatic Copper concentration (μg/g) dry weight 39.3 60 N/A
Kayser–Fleischer ring Absent Absent Absent
mutations in ATP7B gene and other related genes to WD Negative Negative Negative
TABLE 1. Preliminary evaluations
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